Videos

The monoclonal antibody has built on its 18-month portfolio with sustained renal benefits for the at-need patient group.

A survey of 9,004 patients with rheumatic disease―both autoimmune-related and non-autoimmune―shows that patients may need continued medication counseling through the duration of the pandemic, finds a study due to be presented on Friday at the American College of Rheumatology.

Rheumatoid arthritis patients overwhelmingly embraced the idea of collecting patient reported outcomes by smartwatch, shows a study due to be presented on Monday in a presentation to be given at the American College of Rheumatology annual meeting.

An interview with a study author on implementing artificial intelligence into rheumatic care.

Psychosocial factors, such as support, depression, coping, and optimism are associated with pain, function, and satisfaction two years after total knee arthroplasty, shows a study from MD Anderson Cancer Center.

For kidney transplant patients with gout, the use of anti-inflammatory drugs and urate-lowering therapies typically used to prevent flares and slow the progression disease, are associated with the risk of adverse events. In this interview, Dr. Abdul Abdellatif describes a clinical trial that shows pegloticase may be suitable for transplant patients with gout.

The American College of Rheumatology has launched a project designed to resolve inequities in care for patients with systemic lupus erythematosus, a condition that is two or three times more common among ethnic minorities. In this interview, S. Sam Lim, M.D., MPH, chair of ACR’s Collaborative Initiatives Special Committee, tells us more about the project.

From COVID-19 presentations to emerging new therapies for chronic kidney disease, Dr. Bradley Marder, medical director of nephrology with Horizon Therapeutics, offers his take on the most memorable moments from the American Society for Nephrology/Kidney Week annual meeting which wrapped this week.

In today's featured video, we talk with Dr. Brad Marder, medical director at Horizon Therapeutics, who shares with us the details of three studies presented at the American Society of Nephrology annual meeting which is taking place this week online. The studies highlight the preliminary results of clinical trials for new gout treatments. In this interview, he explains why this research is important.

Patients with inflammatory arthritis and osteoarthritis should be participating in four different types of exercise: cardiovascular, strength, flexibility, and balance. But a new study shows that patients are overly focused on cardiovascular exercise and not enough on exercise types designed to strengthen and protect joints and bones.

In this video, rheumatologist Vaneet Kaur Sandhu, M.D., addresses the workforce shortage in rheumatology. It should be addressed on all fronts, she says. If the workforce shortage doesn't turnaround patients in underserved areas will continue to be treated by physicians, albeit well-intended physicians, with little to no experience in rheumatic disease. Learn more in this interview.

Stress and anxiety can wreak havoc on one's health and hinder recovery, particularly for patients with chronic conditions, such as rheumatoid arthritis. In an article published online Sept. 13 in ACR Open Rheumatology, Joshua F. Baker, M.D., and colleagues report the results of study that finds veterans with rheumatoid arthritis and comorbid PTSD, depression, or anxiety, have poor persistence of methotrexate and TNFi therapies leading to worse outcomes. He addresses the study findings in this interview.

In today’s one-on-one interview, we talk with Dimitrios A. Pappas, M.D., MPH, scientific director of the Corrona RA Registry and an adjunct professor with Columbia University. He and his team recently published results from the registry in ACR Open Rheumatology which show that rheumatoid arthritis patients may be able to maintain remission or low disease activity with etanercept (Enbrel, Amgen) monotherapy long-term treatment.

Dr. Bradley Marder, medical director of nephrology with Horizon Therapeutics, addresses the role of diet in managing gout.

Gout is not only an intermittent disease that affects peripheral joints, it’s a disease that's systemic in nature and progressive, says Dr. Bradley Marder, medical director of nephrology with Horizon Therapeutics. As a nephrologist, he sees gout as a kidney disease. In this interview, he explains why.

The use of biologics, JAK inhibitors and small molecule medications has become increasingly common for patients with psoriatic arthritis. Findings from the recent Psoriatic Arthritis In America 2020 survey by Health Union shows that of 1,120 patients surveyed, most patients (61 percent) are satisfied with the care they receive from their doctors, but they still struggle with flares and only 12 percent are satisfied with their care plan. In this interview, Brian Green, vice president of community development at Health Union, reviews the results of their latest survey.

Today, we talk with Dr. Sarah French, a rheumatologist with the University of California at San Francisco. Dr. French recently published a review in Current Osteoporosis Reports that addresses successes and failures in quality improvement initiatives in osteoporosis. Through the MIPS program, healthcare providers are required to select six quality measures. And while they may be performing well on osteoporosis screenings, their track record on osteoporosis management isn't fairing as well. Dr. French has identified this as an area for improvement. In this interview, she explains how.

In today’s one-on-one interview, we talk with Dr. Richard Furie who is chief of rheumatology at Northwell Health in New York. Dr. Furie is the lead investigator of a study on lupus nephritis just published in the New England Journal of Medicine. Dr. Furie and colleagues from the Feinstein Institutes for Medical Research reported that belimumab with standard therapy has been shown to be an effective treatment for lupus nephritis. If the treatment is approved by the U.S. Food and Drug Administration, it would be the first of its kind for this condition. In this presentation, Dr. Furie tell us more.

Three key issues with using the technology over in-person visits.

Care of rheumatic patients must factor in cradiovascular risk and conditions.

The recently published American College of Rheumatology guidelines on reproductive health is a great resource for rheumatologists.

How rheumatologists use telemedicine during COVID-19.

Leveraging telemedicine during COVID-19.

An expert discusses the role of the rheumatologist in managing cardiovascular risk factors as well as current gaps in the field.

An expert explains resources for pain related to rheumatic conditions.

MIS-C is a condition recently recognized in children with COVID-19.

Rheumatologists and OB-GYNs must communicate openly with each other and to patients with rheumatic diseases who are considering pregnancy.

How providers of multiple specialists can come together to help 1 patient.

An expert dermatologist explains.

COVID-19 is associated with its own cytokine storm syndrome.